1. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies;Linch;Nat Rev Clin Oncol,2014
2. PICASSO III: a phase III, placebo-controlled study of doxorubicin with or without palifosfamide in patients with metastatic soft tissue sarcoma;Ryan;J Clin Oncol,2016
3. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial;Seddon;Lancet Oncol,2017
4. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial;Tap;Lancet Oncol,2017
5. Phase III soft tissue sarcoma trials: success or failure?;Lee;Curr Treat Options Oncol,2017